Brunke Karen J 4
4 · CytoDyn Inc. · Filed Sep 8, 2022
Insider Transaction Report
Form 4
CytoDyn Inc.CYDY
Brunke Karen J
Director
Transactions
- Award
Non-qualified stock option (right to buy)
2022-09-06+247,111→ 247,111 totalExercise: $0.50Exp: 2032-09-06→ Common Stock (247,111 underlying) - Award
Non-qualified stock option (right to buy)
2022-09-06+37,500→ 37,500 totalExercise: $0.50From: 2022-09-06Exp: 2032-09-06→ Common Stock (37,500 underlying)
Footnotes (1)
- [F1]As of August 31, 2022, 61,777 shares have vested; the balance will vest in nine equal monthly installments beginning on September 1, 2022, subject to Continuous Service (as the term is defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.